EUDA Health Holdings Limited

NASDAQ:EUDA

Medical - Care Facilities

Healthcare
$17.70 +14.19%

+$2.20 today

Market cap
$53.00M
Beta
0.59
P/E (TTM)
-7.9
EPS (TTM)
-$1.79
52W Low $5.26High $71.20

Volume 0.04M

Average 0.02M

EUDA EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

EUDA Health Holdings LimitedNASDAQ: EUDA

EBITDA · Q2 FY2026 · quarter ended Jun 2026

EBITDA remains negative

Q2 FY2026 EBITDA was -$322.42K, compared with -$476.87K a year earlier. Trailing-twelve-month EBITDA was -$3.28M.

Context

  • EBITDA amounted to 30.7% of revenue in FY2025, down 403.8 pp from a year earlier.
  • EBITDA grew in size in 1 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether EBITDA reaches the consensus estimate from 1 analysts of $3.87M (+284.9%) for the fiscal year ending Dec 2026, a step up from the +88.0% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
-$322.42K+0.0% QoQ
Last fiscal yearDec 2025
-$2.09M+88.0% YoY
LTMJun 2026
-$3.28M-77.0% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+32.4%-415.0%-447.4 pp
1 year+88.0%+284.9%+196.9 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

USD · from the income statement

Latest · FY2025
(2.09M) USD
Year-over-year change
+88.0%
Reported Analyst consensus estimate

EBITDA vs competitors

How EUDA compares with its peers on the latest reported figures

  • Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -77.0% is the 7th highest of 8, against a peer median of -10.6%.
  • EBITDA amounts to 26.9% of revenue for EUDA, versus a peer median of 152.9%.
EUDA Competitors
EBITDA for EUDA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
FONRFONAR CorporationLTM Mar 2026$15.91M USD-15.8%-12.5%15.1%
EUDAEUDA Health Holdings LimitedLTM Jun 2026-$3.28M USD-77.0%—26.9%
ZTEKZentek Ltd.LTM Mar 2026-CA$9.7M CAD-3.8%—5840.5%
HYPRHyperfine, Inc.LTM Mar 2026-$33.15M USD+15.7%—216.2%
DTILPrecision BioSciences, Inc.LTM Mar 2026-$40.42M USD-143.9%—89.7%
AMWLAmerican Well CorporationLTM Mar 2026-$53.01M USD+56.9%—22.3%
ATYRaTyr Pharma, Inc.LTM Mar 2026-$68.69M USD-10.6%—36154.2%
GUTSFractyl Health, Inc. Common StockLTM Mar 2026-$106.88M USD-21.2%——
Peer median (excluding EUDA) —-10.6%-12.5%152.9%

Competitors are the stored peer set for EUDA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue4.56M3.76M3.71M4.01M6.82M
Cost of Revenue3.31M2.89M2.86M3.25M3.83M
Gross Profit1.25M870K842.08K762.16K2.99M
Gross Margin27.4%23.1%22.7%19.0%43.9%
Research & Development129.27K17.21K00249
Selling, General & Admin1.81M6.75M4.8M3.34M5.43M
Operating Expenses1.81M13.09M4.8M18.1M5.43M
Depreciation & Amortization264.1K172.02K119.35K173.22K406.48K
EBITDA1.34M(24.64M)(8.29M)(17.42M)(2.09M)
EBITDA Margin29.4%-654.6%-223.7%-434.4%-30.7%
Operating Income(559.99K)(5.72M)(3.96M)(17.34M)(2.44M)
Operating Margin-12.3%-151.9%-106.9%-432.2%-35.8%
Interest Income1.92M0000
Interest Expense127.13K93.78K23.23K44.89K228.62K
Other Income / Expenses2.23M(19.21M)(4.47M)(307.38K)(285.26K)
Income Before Tax1.67M(24.93M)(8.43M)(17.64M)(2.73M)
Pre-Tax Margin36.6%-662.3%-227.6%-439.8%-40.0%
Income Tax Expense46.49K(20.79K)0(4.38K)41.94K
Net Income864.83K(24.88M)(10.04M)(15.36M)(2.77M)
Net Margin19.0%-661.1%-270.9%-382.9%-40.7%
EPS (Basic)1.87(41.40)(8.80)(9.40)(1.49)
EPS (Diluted)1.87(41.40)(8.80)(9.40)(1.49)
Weighted Avg Shares462.67K601.48K1.15M1.62M1.86M
Weighted Avg Shares (Diluted)462.67K601.48K1.15M1.62M1.86M

EUDA Health Holdings Limited

NASDAQ:EUDA

Intrinsic Alpha fair value

Locked

Current Price

$17.70

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.